MAIA Biotechnology, Inc.MAIANYSE
Loading
SG&A Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+1379.1%
5Y CAGR+561.3%
Studio
Year-over-Year Change

Year-over-year SG&A expense growth

3Y CAGR
+1379.1%/yr
Annual compound
5Y CAGR
+561.3%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
12650.4x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025139830.64%
2024-23.40%
202347.64%
202243.21%
2021-22.89%
202011.05%
20190.00%